A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis

Distal Subungual Onychomycosis Clinical Trial

Official title:
A Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TMI-358 in the Treatment of Distal Subungual Onychomycosis of the Toenail

Status Terminated

Clinical Trial Summary

The purpose of this study is to determine if a local treatment is effective for the treatment of toenail fungus (distal subungual onychomycosis).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01093118
Study type	Interventional
Source	Talima Therapeutics, Inc.
Contact
Status	Terminated
Phase	Phase 2
Start date	September 2009

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02866032` - Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)	Phase 3
Completed	`NCT02859519` - A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)	Phase 3
Completed	`NCT04188574` - A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail	Phase 2
Completed	`NCT01814020` - An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)	Phase 2